News & Perspective

Jun 07, 2019

Jun 07, 2019

News Scan for Jun 07, 2019

New resistant-TB drug
Polio in 3 nations
TB test shortage
Avian flu in Mexico, South Africa

May 13, 2019

May 13, 2019

News Scan for May 13, 2019

MERS in Saudi Arabia
Rocky Mountain spotted fever
Rift Valley fever on Mayotte
Grant for TB research
Canine brucellosis in Iowa

Apr 04, 2019

Apr 04, 2019

Stewardship / Resistance Scan for Apr 04, 2019

Stewardship in nursing homes
US MDR-TB treatment

Mar 29, 2019

Mar 29, 2019

Stewardship / Resistance Scan for Mar 29, 2019

Multidrug-resistant E coli in food
XDR-TB outcomes
Restaurant chain antibiotics pledge

Mar 20, 2019

Mar 20, 2019

Stewardship / Resistance Scan for Mar 20, 2019

Gloves, gowns, and MDROs
WHO drug-resistant TB guidelines
Antibiotic development partnership
Lung disease bacteria in tap water

Mar 19, 2019

Mar 19, 2019
Using stethoscope to assess lungs

Report highlights success, challenges in fight to end TB

Though incidence is down, treatment success for resistant strains is low.

Mar 14, 2019

Mar 14, 2019
Mycobacterium tuberculosis bacteria

Trial data support shorter drug-resistant TB regimen

Short-course therapy led to a favorable outcome in 79% of patients, compared with 80% in long-course patients.

Mar 11, 2019

Mar 11, 2019

Stewardship / Resistance Scan for Mar 11, 2019

VA outpatient prescribing
FDA to review new TB drug

Feb 08, 2019

Feb 08, 2019

Stewardship / Resistance Scan for Feb 08, 2019

Inadequate TB drug-susceptibility testing
New UK guidance on antibiotics for acute cough

Jan 09, 2019

Jan 09, 2019
Doctor prescribing using electronic tablet

Study sheds more light on delamanid role in treating MDR-TB

Safety profile was good, and sensitivity analysis favored delamanid as part of MDR-TB treatment.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»